Gillian C. Ivers-Read
2010
In 2010, Gillian C. Ivers-Read earned a total compensation of $396.8K as EVP of Technical Operations and Chief Regulatory Officer at Clovis Oncology.
Compensation breakdown
| Bonus | $52,000 |
|---|---|
| Salary | $325,000 |
| Other | $19,768 |
| Total | $396,769 |
Ivers-Read received $325K in salary, accounting for 82% of the total pay in 2010.
Ivers-Read also received $52K in bonus and $19.8K in other compensation.
Rankings
In 2010, Gillian C. Ivers-Read's compensation ranked 8,400th out of 10,439 executives tracked by ExecPay. In other words, Ivers-Read earned more than 19.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,400 out of 10,439 | 20th |
Division Manufacturing | 3,130 out of 3,838 | 18th |
Major group Chemicals And Allied Products | 751 out of 921 | 19th |
Industry group Drugs | 533 out of 680 | 22nd |
Industry Pharmaceutical Preparations | 395 out of 481 | 18th |
Source: SEC filing on April 29, 2013.
Ivers-Read's colleagues
We found three more compensation records of executives who worked with Gillian C. Ivers-Read at Clovis Oncology in 2010.
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019